SHI introduces new Acne Clinic

The Skin Health Institute is opening an Acne Clinic on 24 February for all patients aged 12 and above with a valid GP referral.

Acne is one of the most common skin conditions, and generally peaks in adolescence and early adulthood, affecting around 85% of people between the ages of 12 to 24. Though it is often thought of as a teenage problem, acne can occur in people of any age, though it grows less common as time goes on.

Hormones and stress are the main causes of acne with research showing that increased stress is linked to new outbreaks or worsening acne.

Acne is a medical condition, so it is sensible to seek medical advice, especially if it is affecting a patient’s mental health.

Medical treatment for acne should be provided sooner rather than later as it can reduce the risk of permanent physical scars and help with the emotional distress acne can sometimes cause.

When a patient visits our Acne Clinic to receive treatment, our treating dermatologist, Associate Professor Aaron Robinson, will consider the patients circumstances such as the extent and severity of their acne, if they have scars or are at risk of scarring, as well as the emotional and social impact of their acne.

Treatment may include providing guidance in choosing the right skin care products to help control acne, prescribing of medication or suggestion of potential lifestyle changes.

We want to make it easier for GPs to refer to our Acne Clinic, and indeed any of our clinics, so we have taken previous feedback on board and are changing our referral process.

GPs can now refer their patients directly to the Skin Health Institute for the specific skin condition they believe requires treatment.

The new Acne Clinic will be held on the last Friday of every month with our first appointments available on February 24.

We encourage our existing GPs start referring their patients for their acne problems and for interested patients to see their GP for a referral to the Skin Health Institute Acne Clinic now.

Please send your referral to [email protected] and contact us on 03 9623 9400 to book an appointment.

Psoriasis, a chronic inflammatory skin condition, affects millions of individuals worldwide, including a significant number of Australians. This August, during Psoriasis Awareness Month, we aim to shed light on this prevalent condition, raise awareness, and emphasise the importance of empathy and support for those living with psoriasis.

In Australia, psoriasis is estimated to impact approximately 2-3% of the population, making it a relatively common dermatological concern. Despite its prevalence, psoriasis remains widely misunderstood, leading to misconceptions and stigmatisation among patients.

At the Skin Health Institute, we have committed our support to Psoriasis Awareness Month with a mission to create empathy and awareness for people with psoriasis and promote a better understanding of this condition. We recognise that beyond medical treatment, patients need compassionate support and understanding from their communities. Through various initiatives, we strive to foster an environment of compassion and knowledge, allowing patients to feel heard and supported as they learn to manage their condition.

Our dedication to enhancing dermatological care extends to providing the latest treatment options. Our Advanced Targeted Therapies Clinic offers cutting-edge therapies that specifically address psoriasis, tailored to each patient’s unique needs. Our expert dermatologists work closely with patients to develop personalised treatment plans, empowering them to manage their condition effectively and improve their quality of life.

Education is key to unlocking progress in dermatology, so through our suite of educational resources, we seek to help health professionals to stay at the forefront of their clinical practice. Our Masterclasses, GP Workshops, Advanced Therapeutics Education Portal, and Spot Diagnosis podcast episodes provide valuable insights and updates on psoriasis management and treatment options.

As part of our commitment to advancing psoriasis research, we are actively conducting clinical trials focused on nail and body psoriasis. These trials play a crucial role in uncovering innovative treatments and improving outcomes for people with psoriasis. By participating in our clinical trials, individuals not only contribute to medical advancements but also have the opportunity to access potential breakthrough therapies.

During Psoriasis Awareness Month and beyond, we stay dedicated in the pursuit of improving patient outcomes, expanding healthcare professional knowledge and advancing treatment options.         

Scroll to Top